Experience with SARS-CoV-2 in an orthopaedic hospital

• Published in: Infection prevention in practice Vol. 5; no. 1; p. 100260
• Main Authors: Oliveira, Priscila R., Carvalho, Vladimir C., Anjos, Angelica M., Melo, Vanessa F., Leite, Cesar, Silva, Adriana C., Maluf, Natalya Z., Silva, Jorge S., Lima, Ana Lucia L.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01-03-2023; Published by Elsevier Ltd on behalf of The Healthcare Infection Society; Elsevier
• Subjects: Control; COVID-19; Nosocomial infection; Prevention; SARS-CoV-2; Short Report; COVID-19; Prevention; Nosocomial infection; SARS-CoV-2; Control
• ISSN: 2590-0889; 2590-0889
• DOI: 10.1016/j.infpip.2022.100260

Concerns about nosocomial transmission of SARS-CoV-2 have been described since the COVID-19 pandemic was first reported and cases of hospital-acquired (HA) COVID-19 and COVID-19 outbreaks have been reported even in clinical areas not intended for the specific care of COVID-19 and declared as “non-COVID” areas.
Retrospective analysis of measures to prevent of hospital acquisition of COVID-19 in patients admitted to a tertiary referral specialist orthopaedic hospital in Brazil in which emergency care was maintained during the pandemic.
The proportion of HA-COVID-19 (0.07%) was lower than the value reported for general healthcare in Brazil (0.72%, P<0.001). The integration of several clinical teams to maintain a constant surveillance system, as well as the immediate isolation of patients with any compatible symptoms of COVID-19 and the restriction from work and the testing of symptomatic healthcare workers, were an important part of the strategies adopted.
We suggest that the described strategies for preventing the nosocomial spread of SARS-CoV-2 contributed to the observed proportion of HA-COVID-19 to be significantly lower than the reported national value. Future studies that investigate these and other preventative measures are important so that hospitals are prepared for further periods of a high incidence of COVID-19, as well as for other epidemics associated with respiratory transmission.